InsidersTradesSigma
Follow the Liminatus Pharma, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €7.1m. The latest transaction was reported on 14 July 2026 (J). Among the most active insiders: Valetudo Therapeutics LLC. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Liminatus Pharma, Inc. is a pharmaceutical company focused on developing innovative treatments. It is listed on the XNAS market.